What is Array?
Array operates at the intersection of event technology and life sciences, providing a comprehensive suite of tools designed to optimize knowledge transfer and participant engagement. By integrating technical production expertise with advanced analytics, the company enables organizations to capture granular data on attendee behavior. This unique value proposition allows life sciences firms to transform standard meetings into data-rich environments, achieving engagement rates exceeding 90%. With nearly two decades of operational history and experience spanning over 10,000 meetings, Array has established itself as a critical infrastructure partner for hybrid, virtual, and in-person professional forums.
How much funding has Array raised?
Array has raised a total of $2.1M across 2 funding rounds:
Debt
$1M
Debt
$1.1M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.1M led by PPP
Key Investors in Array
PPP
Public-Private Partnership
What's next for Array?
The recent influx of capital positions Array to accelerate its product roadmap and expand its footprint within the global life sciences market. As the industry shifts toward more sophisticated, data-driven engagement models, Array is well-positioned to leverage its existing analytics capabilities to offer deeper, more actionable insights for its enterprise clients. Future growth strategies will likely focus on enhancing the scalability of its hybrid meeting platforms and deepening its integration with existing pharmaceutical enterprise systems. By maintaining its focus on high-impact engagement, the company is poised to capitalize on the increasing demand for digital transformation in medical education and professional collaboration.
See full Array company page
